The Board of Horizon Therapeutics plc…confirms that it is engaged in highly preliminary discussions with Amgen Inc., Janssen Global Services…[JNJ] and Sanofi…, which may or may not lead to an offer being made for the entire share capital of the Company. There can be no certainty that any offer will be made for the Company.
The disclosure is in accordance with securities law in Ireland, where HZNP is domiciled.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”